Cargando…
Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections
Asthma is a common chronic respiratory disease that affects millions of people worldwide. Patients with allergic asthma, the most prevalent asthma endotype, are widely considered to possess a defective immune response against some respiratory infectious agents, including viruses, bacteria and fungi....
Autores principales: | Flores-Torres, Armando S., Samarasinghe, Amali E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974821/ https://www.ncbi.nlm.nih.gov/pubmed/35386652 http://dx.doi.org/10.3389/falgy.2022.852067 |
Ejemplares similares
-
Therapeutic efficacy of omalizumab in children with moderate-to-severe allergic asthma combined with chronic sinusitis
por: Chong, Weikun, et al.
Publicado: (2023) -
Immunogenetics and pharmacogenetics of allergic asthma in Africa
por: Mabelane, Tshegofatso, et al.
Publicado: (2023) -
New Insights on the Role of pentraxin-3 in Allergic Asthma
por: Koussih, Latifa, et al.
Publicado: (2021) -
Deletion of Miro1 in airway club cells potentiates allergic asthma phenotypes
por: Bruno, Sierra, et al.
Publicado: (2023) -
The role of the respiratory microbiome in asthma
por: Campbell, Christina D., et al.
Publicado: (2023)